Learn about KEYTRUDA® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers. Visit the patient website.

Side effects may occur while taking KEYTRUDA During treatment with KEYTRUDA, side effects can occur and should be treated as early as possible. In clinical trials with KEYTRUDA, some patients …

View tips and resources that may help while receiving KEYTRUDA® (pembrolizumab) including what to expect with your first infusion appointment and what to know about your treatment schedule.

Learn about cost information, insurance, and potential financial assistance options with KEYTRUDA® (pembrolizumab). See more at keytruda.com.

See how long treatment administration with KEYTRUDA® (pembrolizumab) may take, explore your options for receiving it, and learn what to expect during the process. Start here.

Learn how KEYTRUDA® (pembrolizumab) works with your immune system to help fight cancer cells. Watch two videos about immunotherapy and how it works in the body.

Learn about a treatment option that may help certain patients with high-risk non-muscle invasive bladder cancer (NMIBC).

Learn about treatment options that may help certain patients with advanced urothelial bladder cancer. Download our brochure for one treatment option containing tips that may help manage side effects …

Learn about an immunotherapy treatment option for advanced MSI-H/dMMR colorectal cancer (CRC). Review clinical trial data and information on relevant biomarkers here.

Learn about an FDA-approved immunotherapy combination treatment for both high-risk early-stage and advanced triple-negative breast cancer (TNBC).